Matches in Wikidata for { <http://www.wikidata.org/entity/Q93052157> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q93052157 description "2019 թվականի ապրիլի 12-ին հրատարակված գիտական հոդված" @default.
- Q93052157 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q93052157 description "im April 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93052157 description "scientific article published on 12 April 2019" @default.
- Q93052157 description "wetenschappelijk artikel" @default.
- Q93052157 description "наукова стаття, опублікована 12 квітня 2019" @default.
- Q93052157 name "A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: clinical benefit is a plausible end point?" @default.
- Q93052157 name "A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: clinical benefit is a plausible end point?" @default.
- Q93052157 type Item @default.
- Q93052157 label "A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: clinical benefit is a plausible end point?" @default.
- Q93052157 label "A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: clinical benefit is a plausible end point?" @default.
- Q93052157 prefLabel "A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: clinical benefit is a plausible end point?" @default.
- Q93052157 prefLabel "A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: clinical benefit is a plausible end point?" @default.
- Q93052157 P1433 Q93052157-9C7D5786-58D2-4709-A67B-C926E3A40E15 @default.
- Q93052157 P1476 Q93052157-D7248B2A-AF7B-4031-B06A-C042C52F6A64 @default.
- Q93052157 P2093 Q93052157-0108CC7C-E5BD-463D-B2F0-3C3064A3F6AD @default.
- Q93052157 P2093 Q93052157-03430B90-1E85-4D7C-A211-50DAEE5DAD3D @default.
- Q93052157 P2093 Q93052157-1D4A451E-8FF0-416B-81EB-98263D2B468A @default.
- Q93052157 P2093 Q93052157-2158B474-C134-497C-A7D9-8F0E8E5EAD04 @default.
- Q93052157 P2093 Q93052157-47E108BF-0D33-4EC6-9C3A-C62C9EAE1F98 @default.
- Q93052157 P2093 Q93052157-4B94A7E3-0C2E-4BD4-8B09-4D51AED5953A @default.
- Q93052157 P2093 Q93052157-4D3E0634-166E-45B9-912E-A88902E44507 @default.
- Q93052157 P2093 Q93052157-6B52128A-8607-4CEE-A76A-6942BB8A74B6 @default.
- Q93052157 P2093 Q93052157-6F7FCFEA-289C-47E8-AF2B-BAB7FE65DAC7 @default.
- Q93052157 P2093 Q93052157-7901EF3D-C38F-4521-825B-4FF9E5307786 @default.
- Q93052157 P2093 Q93052157-92DF3C94-1BB2-4E86-B7F9-1DA0A58081F1 @default.
- Q93052157 P2093 Q93052157-BB98B779-C4D0-4099-96EC-327C878BD252 @default.
- Q93052157 P2093 Q93052157-CC53CB0F-A2F0-49AF-99E3-D4E092A22A5D @default.
- Q93052157 P2093 Q93052157-E2A0C800-85AA-4F00-8522-4BA559E426A7 @default.
- Q93052157 P2093 Q93052157-F030FC29-656F-40DE-AB5F-C849242B57B5 @default.
- Q93052157 P2093 Q93052157-F5D983F5-68D3-4A14-B340-43B4FFF0641E @default.
- Q93052157 P304 Q93052157-2C74B288-8A60-4F84-9096-BA33A286AC3D @default.
- Q93052157 P31 Q93052157-6312F2A5-75E3-4DD2-90AA-03243BA2EE95 @default.
- Q93052157 P356 Q93052157-CD58C638-9E52-4ED4-89D0-522D90528C61 @default.
- Q93052157 P433 Q93052157-626FFBFE-CF14-4330-8BC1-F8CCD2926C86 @default.
- Q93052157 P478 Q93052157-83293D82-9160-40D4-B341-AF9D4EDABCE8 @default.
- Q93052157 P50 Q93052157-3CAF355C-0288-4CF2-9386-05AE08EF4CAD @default.
- Q93052157 P50 Q93052157-48B484DB-5E3F-432F-B2A7-DD0B4DD5E5AD @default.
- Q93052157 P50 Q93052157-ED9C0D93-5C0D-403C-A340-89C3BBEED9B5 @default.
- Q93052157 P577 Q93052157-E3D03A6D-2490-46FA-A473-4CA0BBEE5D0B @default.
- Q93052157 P698 Q93052157-033B6CA7-92B3-48E3-99EC-D61F1A603210 @default.
- Q93052157 P921 Q93052157-C861176D-5292-4ED5-AA70-F5ECEFF4BB69 @default.
- Q93052157 P356 FON-2018-0826 @default.
- Q93052157 P698 30977687 @default.
- Q93052157 P1433 Q2781597 @default.
- Q93052157 P1476 "A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: clinical benefit is a plausible end point?" @default.
- Q93052157 P2093 "Alessandra Fabi" @default.
- Q93052157 P2093 "Alessandra Gonnelli" @default.
- Q93052157 P2093 "Alessandro Molinari" @default.
- Q93052157 P2093 "Antonello Vidiri" @default.
- Q93052157 P2093 "Antonio Tanzilli" @default.
- Q93052157 P2093 "Carmine Maria Carapella" @default.
- Q93052157 P2093 "Fabiola Paiar" @default.
- Q93052157 P2093 "Francesco Cognetti" @default.
- Q93052157 P2093 "Francesco Pasqualetti" @default.
- Q93052157 P2093 "Giuseppe Lombardi" @default.
- Q93052157 P2093 "Irene Terrenato" @default.
- Q93052157 P2093 "Luisa Bellu" @default.
- Q93052157 P2093 "Mariantonia Carosi" @default.
- Q93052157 P2093 "Marta Maschio" @default.
- Q93052157 P2093 "Martina Cantarella" @default.
- Q93052157 P2093 "Vittorina Zagonel" @default.
- Q93052157 P304 "1717-1727" @default.
- Q93052157 P31 Q13442814 @default.
- Q93052157 P356 "10.2217/FON-2018-0826" @default.
- Q93052157 P433 "15" @default.
- Q93052157 P478 "15" @default.
- Q93052157 P50 Q72115386 @default.
- Q93052157 P50 Q81436095 @default.
- Q93052157 P50 Q84801769 @default.
- Q93052157 P577 "2019-04-12T00:00:00Z" @default.
- Q93052157 P698 "30977687" @default.
- Q93052157 P921 Q413299 @default.